Zymeworks Inc. ZYME
Regular-session close
After hours · Nov 20, 4:00 PM ET
- YTD
- -0.72%
- 1 year
- +9.74%
Held by funds
95 US ETFs and mutual funds hold ZYME · largest positions
- VTI 0.00% of fund $34.77M
- IWM 0.04% of fund $31.12M
- NJM 0.04% of fund $28.70M
- FSSNX 0.04% of fund $15.13M
- IBB 0.13% of fund $14.01M
- IWO 0.08% of fund $11.17M
- FIDGX 0.12% of fund $10.86M
- NLO 0.07% of fund $10.01M
- DFAS 0.03% of fund $8.17M
- VTWO 0.04% of fund $7.68M
- BDSKX 0.12% of fund $6.36M
- FESM 0.07% of fund $4.50M
- VHT 0.01% of fund $3.53M
- IJE 0.22% of fund $3.14M
- FBIOX 0.05% of fund $3.04M
- DFMC 0.04% of fund $2.93M
- CANC 1.36% of fund $2.73M
- MDSKX 0.04% of fund $2.40M
- DFAC 0.00% of fund $2.26M
- SPDW 0.01% of fund $2.19M
Ownership
Top institutional holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| EcoR1 Capital, LLC | 36.46% | 22,970,388 | 600.45M | Sep 29, 2026 |
| Rubric Capital Management LP | 11.11% | 7,000,000 | 182.98M | Sep 29, 2026 |
| Blackrock Inc. | 6.69% | 4,212,745 | 110.12M | Sep 29, 2026 |
| Perceptive Advisors Llc | 5.63% | 3,545,501 | 92.68M | Sep 29, 2026 |
| BVF Inc. | 5.50% | 3,464,142 | 90.55M | Sep 29, 2026 |
| Morgan Stanley | 5.14% | 3,236,915 | 84.61M | Sep 29, 2026 |
Top mutual fund holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 2.39% | 1,508,613 | 39.44M | Jun 29, 2026 |
| iShares Trust-iShares Russell 2000 ETF | 1.88% | 1,185,928 | 31.00M | Sep 29, 2026 |
| IVY FUNDS-Nomura Small Cap Growth Fund | 0.95% | 600,846 | 15.71M | Jun 29, 2026 |
| iShares Trust-iShares Biotechnology ETF | 0.85% | 538,110 | 14.07M | Sep 29, 2026 |
| Fidelity Salem Street Trust-Fidelity Small Cap Index Fund | 0.82% | 514,484 | 13.45M | Aug 30, 2026 |
| iShares Trust-iShares Russell 2000 Growth ETF | 0.68% | 425,949 | 11.13M | Sep 29, 2026 |
Included in Plus and up
Sign in to see Institutional ownership
How much funds own from their 13F filings, quarter by quarter, and the largest holders.
Free with an account
Sign in to see Insider activity
Two years of insider buying and selling by month, marked on the price.
Included in Plus and up
Sign in to see Congress trading
Every stock trade disclosed by members of the US Senate and House.
Leadership team
Who runs ZYME, and what each was last paid
Kenneth H. Galbraith, Chairman of the Board, Chief Executive Officer & PresidentAverage age 52
| Name | Title | Pay | Age |
|---|---|---|---|
| Kenneth H. Galbraith | Chairman of the Board, Chief Executive Officer & President | $1.71M | 64 |
| Paul Moore | Chief Scientific Officer | $998K | 59 |
| Paul R. Schneider | Executive VP & General Counsel | — | 55 |
| Stuart Knight | Executive VP & Chief Information Officer | — | — |
| Mark Hollywood | Executive VP & Chief Operating Officer | — | 57 |
| Scott Platshon | Executive VP & Chief Business Officer | — | 35 |
| Bijal Desai | Senior Vice President of Finance | — | — |
| Diana Papove | Vice President of Corporate Communications | — | — |
| Kristin Stafford | Executive VP & CFO | — | 44 |
| Laura O'Connor | Senior VP & Chief Human Resources Officer | — | — |
| Shrinal Inamdar | Vice President of Investor Relations | — | — |
| Suzanne Monahan | Senior VP of Commercial & GM of Theravance Biopharma | — | — |
Pay is the latest total FMP has for each person (salary, bonus, stock and other awards) and can lag the newest proxy statement. Source: Financial Modeling Prep, from the company’s SEC filings.
Free with an account
Sign in to see CEO compensation
What the chief executive was paid each year, by salary, bonus and stock, beside the company's earnings.
Free with an account
Sign in to see Board of directors
Who sits on the board, who chairs it, and how long each director has served.
Insiders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| CIONGOLI GREGORY AUSTIN | Director | Stock Award(Grant) | Aug 11, 2025 | 493,500 |
| ECOR1 CAPITAL, L.L.C. | Beneficial Owner of more than 10% of a Class of Security | Conversion of Exercise of derivative security | Jun 25, 2025 | 0 |
| GALBRAITH KENNETH HARRY | Chief Executive Officer | Sale | Jan 11, 2026 | 226,842 |
| HOLLYWOOD MARK | Chief Operating Officer | Stock Award(Grant) | Jul 5, 2026 | 133,852 |
| MOORE PAUL ANDREW | Officer | Sale | Nov 12, 2026 | 33,756 |
| PATTERSON LEONE D. CPA | Chief Financial Officer | Stock Award(Grant) | Jan 5, 2026 | 459 |
